Chanel Avenant

676 total citations
24 papers, 529 citations indexed

About

Chanel Avenant is a scholar working on Genetics, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chanel Avenant has authored 24 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Immunology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chanel Avenant's work include Estrogen and related hormone effects (13 papers), Reproductive System and Pregnancy (10 papers) and Reproductive Health and Contraception (6 papers). Chanel Avenant is often cited by papers focused on Estrogen and related hormone effects (13 papers), Reproductive System and Pregnancy (10 papers) and Reproductive Health and Contraception (6 papers). Chanel Avenant collaborates with scholars based in South Africa, Botswana and United States. Chanel Avenant's co-authors include Janet P. Hapgood, Roslyn M. Ray, Katharina Ronacher, Ann Louw, Michele Tomasicchio, Nicolette J. D. Verhoog, Andrea Du Toit, S. Stoney Simons, Katie Hadley and Donita Africander and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Chanel Avenant

22 papers receiving 525 citations

Peers

Countries citing papers authored by Chanel Avenant

Since Specialization

Citations

This map shows the geographic impact of Chanel Avenant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chanel Avenant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chanel Avenant more than expected).

Fields of papers citing papers by Chanel Avenant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chanel Avenant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chanel Avenant. The network helps show where Chanel Avenant may publish in the future.

Co-authorship network of co-authors of Chanel Avenant

This figure shows the co-authorship network connecting the top 25 collaborators of Chanel Avenant. A scholar is included among the top collaborators of Chanel Avenant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chanel Avenant. Chanel Avenant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Injectable Contraceptives Differentially Affect Select CD4+ HIV‐1 Target Cells in the Genital Tract but Not Systemically: Implications for HIV‐1 Acquisition 2025 ·American Journal of Reproductive Immunology ·Chanel Avenant, (unknown), (unknown), (unknown), Michele Tomasicchio, G Justus Hofmeyr, Charles Morrison, Pai‐Lien Chen, Janet P. Hapgood	0
2	Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial 2024 ·PLoS ONE ·Mandisa Singata‐Madliki, Jenni Smit, Mags Beksinska, Yusentha Balakrishna, Chanel Avenant, Ivana Beesham, Ishen Seocharan, Joanne Batting, Janet P. Hapgood, G Justus Hofmeyr	4
3	The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial 2024 ·PLoS ONE ·Chanel Avenant, Mandisa Singata‐Madliki, (unknown), Donita Africander, Yusentha Balakrishna, Karl‐Heinz Storbeck, (unknown), (unknown), (unknown), Jenni Smit, Mags Beksinska, Ivana Beesham, Ishen Seocharan, Joanne Batting, G Justus Hofmeyr, Janet P. Hapgood	1
4	Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN 2023 ·PLoS ONE ·Chanel Avenant, (unknown), (unknown), (unknown), Yusentha Balakrishna, (unknown), Mandisa Singata‐Madliki, G Justus Hofmeyr, Jenni Smit, Mags Beksinska, Ivana Beesham, Ishen Seocharan, Joanne Batting, Pai‐Lien Chen, Karl‐Heinz Storbeck, Donita Africander, Janet P. Hapgood	4
5	Glucocorticoids and medroxyprogesterone acetate synergize with inflammatory stimuli to selectively upregulate CCL20 transcription 2023 ·Molecular and Cellular Endocrinology ·(unknown), (unknown), (unknown), Chanel Avenant, Janet P. Hapgood	2
6	Differential off-target glucocorticoid activity of progestins used in endocrine therapy 2022 ·Steroids ·(unknown), Chanel Avenant, (unknown), Donita Africander, Janet P. Hapgood	16
7	Progestogens exhibit progestogen-, promoter- and isoform-specific effects via the progesterone receptor 2022 ·Steroids ·(unknown), Chanel Avenant, Janet P. Hapgood	3
8	Variability and quantification of serum medroxyprogesterone acetate levels 2022 ·Steroids ·(unknown), (unknown), Chanel Avenant, Janet P. Hapgood	2
9	Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence of progestogens 2020 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Chanel Avenant, (unknown), Janet P. Hapgood	0
10	The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations 2019 ·Scientific Reports ·Roslyn M. Ray, Michelle F. Maritz, Chanel Avenant, Michele Tomasicchio, (unknown), Zephne M. van der Spuy, Janet P. Hapgood	22
11	Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms 2019 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Zephne M. van der Spuy, Chanel Avenant, Donita Africander, Karl‐Heinz Storbeck, Janet P. Hapgood	12
12	Reciprocal Modulation of Antiretroviral Drug and Steroid Receptor Function In Vitro 2019 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Zephne M. van der Spuy, Michelle F. Maritz, Chanel Avenant, Janet P. Hapgood	4
13	Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels 2018 ·PLoS ONE ·Michelle F. Maritz, Roslyn M. Ray, (unknown), Michele Tomasicchio, (unknown), (unknown), Chanel Avenant, Janet P. Hapgood	28
14	Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy 2016 ·Pharmacology & Therapeutics ·Janet P. Hapgood, Chanel Avenant, (unknown)	56
15	The Injectable-Only Contraceptive Medroxyprogesterone Acetate, Unlike Norethisterone Acetate and Progesterone, Regulates Inflammatory Genes in Endocervical Cells via the Glucocorticoid Receptor 2014 ·PLoS ONE ·(unknown), Chanel Avenant, Nicolette J. D. Verhoog, Roslyn M. Ray, (unknown), Donita Africander, Janet P. Hapgood	59
16	Differential Glucocorticoid Receptor‐Mediated Effects on Immunomodulatory Gene Expression by Progestin Contraceptives: Implications for HIV‐1 Pathogenesis 2014 ·American Journal of Reproductive Immunology ·Janet P. Hapgood, Roslyn M. Ray, (unknown), Chanel Avenant, Michele Tomasicchio	28
17	The Progestin-Only Contraceptive Medroxyprogesterone Acetate, but Not Norethisterone Acetate, Enhances HIV-1 Vpr-Mediated Apoptosis in Human CD4+ T Cells through the Glucocorticoid Receptor 2013 ·PLoS ONE ·Michele Tomasicchio, Chanel Avenant, Andrea Du Toit, Roslyn M. Ray, Janet P. Hapgood	36
18	Glucocorticoid-independent Repression of Tumor Necrosis Factor (TNF) α-stimulated Interleukin (IL)-6 Expression by the Glucocorticoid Receptor 2011 ·Journal of Biological Chemistry ·Nicolette J. D. Verhoog, Andrea Du Toit, Chanel Avenant, Janet P. Hapgood	41
19	Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity☆ 2010 ·Molecular and Cellular Endocrinology ·Chanel Avenant, Katharina Ronacher, (unknown), Ann Louw, Janet P. Hapgood	35
20	Ligand-selective transactivation and transrepression via the glucocorticoid receptor: Role of cofactor interaction 2008 ·Molecular and Cellular Endocrinology ·Katharina Ronacher, Katie Hadley, Chanel Avenant, (unknown), S. Stoney Simons, Ann Louw, Janet P. Hapgood	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact